Protein phosphatases in the regulation of mitosis
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The accurate segregation of genetic material to daughter cells during mitosis depends on the precise coordination and regulation of hundreds of proteins by dynamic phosphorylation. Mitotic kinases are major regulators of protein function, but equally important are protein phosphatases that balance their actions, their coordinated activity being essential for accurate chromosome segregation. Phosphoprotein phosphatases (PPPs) that dephosphorylate phosphoserine and phosphothreonine residues are increasingly understood as essential regulators of mitosis. In contrast to kinases, the lack of a pronounced peptide-binding cleft on the catalytic subunit of PPPs suggests that these enzymes are unlikely to be specific. However, recent exciting insights into how mitotic PPPs recognize specific substrates have revealed that they are as specific as kinases. Furthermore, the activities of PPPs are tightly controlled at many levels to ensure that they are active only at the proper time and place. Here, I will discuss substrate selection and regulation of mitotic PPPs focusing mainly on animal cells and explore how these actions control mitosis, as well as important unanswered questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, W., Arroyo, J. D., Timmons, J. C., Possemato, R., & Hahn, W. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1103 · Cited by 159 · cited 1×
“…mutations in the PP2A scaffolding subunits as well as B56 regulatory subunits have been identified in a number of cancers and linked to intellectual disability and developmental disorders (Chen et al., 2005; Sablina et al., 2007; Nobumori et al., 2012; Houge et al., 2015; Haesen et al., 2016).”
BackgroundRetractedA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610 · cited 1×
“PP6C is mutated in melanomas, and these mutations prevent the assembly of PP6 holoenzymes and hereby inhibit the phosphatase (Hodis et al., 2012; Krauthammer et al., 2012; Hammond et al., 2013).”
BackgroundSerine/threonine phosphatases: mechanism through structure
Shi, Y. (2009) · Cell · doi:10.1016/j.cell.2009.10.006 · Cited by 1,488 · cited 7×
“16:365–371. https:// doi .org/ 10 .1016/ j .chembiol .2009 .02 .012 Heroes, E., B. Lesage, J. Görnemann, M. Beullens, L. Van Meervelt, and M. Bollen.”
BackgroundInfluentialExome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191 · cited 1×
“PP6C is mutated in melanomas, and these mutations prevent the assembly of PP6 holoenzymes and hereby inhibit the phosphatase (Hodis et al., 2012; Krauthammer et al., 2012; Hammond et al., 2013).”
BackgroundCIP2A inhibits PP2A in human malignancies
Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677 · cited 1×
“An additional mechanism of PP2A inhibition in cancers is through the overexpression of CIP2A and SET, which are inhibitors of the phosphatase (Junttila et al., 2007; Zhou et al., 2017).”
BackgroundCrystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
Cho, U. S., & Xu, W. (2007) · Nature · doi:10.1038/nature05351 · Cited by 459 · cited 1×
“B56 subunits are composed of 15 tetratricopeptide repeats forming a horseshoe-shaped structure (Fig. 2, B and C; Xu et al., 2006, 2008; Cho and Xu, 2007).”
BackgroundStructure of the Protein Phosphatase 2A Holoenzyme
Xu, Y., Xing, Y., Chen, Y., Chao, Y., Lin, Z., Fan, E., Yu, J. W., Strack, S., Jeffrey, P. D., & Shi, Y. (2006) · Cell · doi:10.1016/j.cell.2006.11.033 · Cited by 450
De Novo Mutations in Moderate or Severe Intellectual Disability
Hamdan, F. F., Srour, M., Capo-Chichi, J.-M., Daoud, H., Nassif, C., Patry, L., Massicotte, C., Ambalavanan, A., Spiegelman, D., Diallo, O., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004772 · Cited by 419 · cited 1×
“Disease mutations in PP1β have been linked to intellectual disabilities and delayed development, but if this is through an effect on mitosis is not clear (Hamdan et al., 2014; Ma et al., 2016a).”
BackgroundIdentification of specific PP2A complexes involved in human cell transformation
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., & Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00026-1 · Cited by 325 · cited 1×
“PP2A was identified as the target of the small tumor antigen of the transforming viruses SV40 and polyomavirus, and small tumor antigen appears to mainly displace B56γ from the PP2A holoenzyme (Chen et al., 2004; Mumby, 2007).”
BackgroundPP2A: Unveiling a Reluctant Tumor Suppressor
Mumby, M. (2007) · Cell · doi:10.1016/j.cell.2007.06.034 · Cited by 295
Foley, E. A., Maldonado, M., & Kapoor, T. M. (2011) · Nature Cell Biology · doi:10.1038/ncb2327 · Cited by 267
Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases.
Dohadwala, M., da Cruz e Silva, E. F., Hall, F. L., Williams, R. T., Carbonaro-Hall, D. A., Nairn, A. C., Greengard, P., & Berndt, N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6408 · Cited by 259
Aurora kinases and protein phosphatase 1 mediate chromosome congression through regulation of CENP-E
Kim, Y., Holland, A. J., Lan, W., & Cleveland, D. W. (2010) · Cell · doi:10.1016/j.cell.2010.06.039 · Cited by 233
Direct binding between BubR1 and B56–PP2A phosphatase complexes regulate mitotic progression
Kruse, T., Zhang, G., Larsen, M. S. Y., Lischetti, T., Streicher, W., Kragh Nielsen, T., Bjørn, S. P., & Nilsson, J. (2013) · Journal of Cell Science · doi:10.1242/jcs.122481 · Cited by 205
Self-citationMolecular mechanism of APC/C activation by mitotic phosphorylation
Zhang, S., Chang, L., Alfieri, C., Zhang, Z., Yang, J., Maslen, S., Skehel, M., & Barford, D. (2016) · Nature · doi:10.1038/nature17973 · Cited by 203
A PP2A-B55 recognition signal controls substrate dephosphorylation kinetics during mitotic exit
Cundell, M. J., Hutter, L. H., Nunes Bastos, R., Poser, E., Holder, J., Mohammed, S., Novak, B., & Barr, F. A. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201606033 · Cited by 193
A PP1-PP2A phosphatase relay controls mitotic progression
Grallert, A., Boke, E., Hagting, A., Hodgson, B., Connolly, Y., Griffiths, J. R., Smith, D. L., Pines, J., & Hagan, I. M. (2015) · Nature · doi:10.1038/nature14019 · Cited by 188 · cited 3×
“Furthermore, studies of fission yeast suggest that PP1 directly binds PP2A-B55 through an RVxF motif in B55 to activate PP2A-B55, and this mechanism might also extend to humans because the binding site for PP1 in B55 is conserved (Grallert et al., 2015).”
BackgroundLongin, S., Zwaenepoel, K., Louis, J. V., Dilworth, S., Goris, J., & Janssens, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704059200 · Cited by 184
Expanding the PP2A Interactome by Defining a B56-Specific SLiM
Wang, X., Bajaj, R., Bollen, M., Peti, W., & Page, R. (2016) · Structure · doi:10.1016/j.str.2016.09.010 · Cited by 149
B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability
Houge, G., Haesen, D., Vissers, L. E. L. M., Mehta, S., Parker, M. J., Wright, M., Vogt, J., McKee, S., Tolmie, J. L., Cordeiro, N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79860 · Cited by 124 · cited 1×
“In addition, loss-of-function mutations in the PP2A scaffolding subunits as well as B56 regulatory subunits have been identified in a number of cancers and linked to intellectual disability and developmental disorders (Chen et al., 2005; Sablina et al., 2007; Nobumori et al., 2012; Houge et al., 2015; Haesen et al., 2…”
BackgroundHaesen, D., Abbasi Asbagh, L., Derua, R., Hubert, A., Schrauwen, S., Hoorne, Y., Amant, F., Waelkens, E., Sablina, A., & Janssens, V. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3342 · Cited by 124
Kruse, T., Biedenkopf, N., Hertz, E. P. T., Dietzel, E., Stalmann, G., López-Méndez, B., Davey, N. E., Nilsson, J., & Becker, S. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.11.034 · Cited by 92
Self-citationWang, J., Wang, Z., Yu, T., Yang, H., Virshup, D. M., Kops, G. J. P. L., Lee, S. H., Zhou, W., Li, X., Xu, W., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0283-4 · Cited by 80
McClinch, K., Avelar, R. A., Callejas, D., Izadmehr, S., Wiredja, D., Perl, A., Sangodkar, J., Kastrinsky, D. B., Schlatzer, D., Cooper, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-0123 · Cited by 78 · cited 1×
“Given the central role of PP2A in several human diseases, the development of PP2A modulators that either increase or decrease its activity is being developed (Lai et al., 2018; McClinch et al., 2018).”
BackgroundBastos, R. N., Cundell, M. J., & Barr, F. A. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201409129 · Cited by 73 · cited 2×
“For instance, B56γ and B56δ preferentially localize to kinetochores while B56γ and B56ε preferentially localize to the midzone during mitotic exit (Bastos et al., 2014; Nijenhuis et al., 2014).”
BackgroundCheng, Y., Liu, W., Kim, S.-T., Sun, J., Lu, L., Sun, J., Zheng, S. L., Isaacs, W. B., & Xu, J. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.05.002 · Cited by 64 · cited 1×
“The B55α subunit is down-regulated in prostate cancer, and PP2A-B55 might also affect the progression of Alzheimer’s disease through dephosphorylation of the Tau protein (Gong et al., 1995; Cheng et al., 2011; Mao et al., 2011).”
BackgroundLai, D., Chen, M., Su, J., Liu, X., Rothe, K., Hu, K., Forrest, D. L., Eaves, C. J., Morin, G. B., & Jiang, X. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8735 · Cited by 47 · cited 1×
“Given the central role of PP2A in several human diseases, the development of PP2A modulators that either increase or decrease its activity is being developed (Lai et al., 2018; McClinch et al., 2018).”
Background
Cited by
Kruse, T., Gnosa, S. P., Nasa, I., Garvanska, D. H., Hein, J. B., Nguyen, H., Samsøe‐Petersen, J., Lopez‐Mendez, B., Hertz, E. P. T., Schwarz, J., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103695 · Cited by 97
Self-citationA dynamic charge-charge interaction modulates PP2A:B56 substrate recruitment
Wang, X., Garvanska, D. H., Nasa, I., Ueki, Y., Zhang, G., Kettenbach, A. N., Peti, W., Nilsson, J., & Page, R. (2020) · eLife · doi:10.7554/elife.55966 · Cited by 53
“Cellular and biochemical studies further confirmed this by demonstrating the role of PP2A in orchestrating mitotic events, cell apoptosis, metabolism and many other fundamental cellular signaling pathways (Nilsson, 2019; Reid et al., 2013; Reynhout and Janssens, 2019; Wlodarchak and Xing, 2016).”
BackgroundSelf-citationVit, G., Duro, J., Rajendraprasad, G., Hertz, E. P. T., Holland, L. K. K., Weisser, M. B., McEwan, B. C., Lopez‐Mendez, B., Sotelo‐Parrilla, P., Jeyaprakash, A. A., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022110611 · Cited by 34
Self-citationSubstrate recognition principles for the PP2A-B55 protein phosphatase
Kruse, T., Garvanska, D. H., Varga, J. K., Garland, W., McEwan, B. C., Hein, J. B., Weisser, M. B., Benavides-Puy, I., Chan, C. B., Sotelo-Parrilla, P., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp5491 · Cited by 26
Self-citationUeki, Y., Hadders, M. A., Weisser, M. B., Nasa, I., Sotelo-Parrilla, P., Cressey, L. E., Gupta, T., Hertz, E. P. T., Kruse, T., Montoya, G., et al. (2021) · The EMBO Reports · doi:10.15252/embr.202052295 · Cited by 16
Self-citation
Metadata
- Authors
- Nilsson, J.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2018-11-16
- Volume
- 218
- Issue
- 2
- Pages
- 395-409
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2900538053
- Cited by
- 112
- References
- 27
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.